Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Shields

Showing results (61-70 of 213) with videos related to

Pageof 22
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 24, 2017
A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on InflammationPeter G Shields, Micah Berman, Theodore M Brasky, et al.
Lung Cancer (Amsterdam, Netherlands)|June 8, 2020
Clinical and Molecular Correlates of Tumor Mutation Burden in Non-Small Cell Lung CancerMichael F Sharpnack, Ju Hwan Cho, Travis S Johnson, et al.
International Journal of Cancer|July 24, 2009
Elevated lung cancer risk is associated with deficiencies in cell cycle checkpoints: genotype and phenotype analyses from a case-control studyYun-Ling Zheng, Ourania Kosti, Christopher A Loffredo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 5, 2009
Methods used in internal industry clinical trials to assess tobacco risk reductionVaughan W Rees, Jennifer M Kreslake, Richard J O'Connor, et al.
Journal of the National Cancer Institute|September 13, 2007
Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity geneSharon R Pine, Leah E Mechanic, Stefan Ambs, et al.
Addiction (Abingdon, England)|September 11, 2016
Reduced nicotine content cigarettes and use of alternative nicotine products: exploratory trialDorothy K Hatsukami, Xianghua Luo, Laura Dick, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 5, 2009
Assessing consumer responses to potential reduced-exposure tobacco products: a review of tobacco industry and independent research methodsVaughan W Rees, Jennifer M Kreslake, K Michael Cummings, et al.
Pharmacogenetics and Genomics|May 19, 2005
Association of catechol-O-methyltransferase with smoking cessation in two independent studies of womenSusan Colilla, Caryn Lerman, Peter G Shields, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 15, 2014
Genetic variation in adipokine genes and associations with adiponectin and leptin concentrations in plasma and breast tissueAdana A M Llanos, Theodore M Brasky, Jeena Mathew, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
TP53 mutation spectrum in lung cancer is not different in women and menAizen J Marrogi, Leah E Mechanic, Judith A Welsh, et al.
Pageof 22

Showing results (61-70 of 213) with videos related to

Sort By:
Pageof 22
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 24, 2017
A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on InflammationPeter G Shields, Micah Berman, Theodore M Brasky, et al.
Lung Cancer (Amsterdam, Netherlands)|June 8, 2020
Clinical and Molecular Correlates of Tumor Mutation Burden in Non-Small Cell Lung CancerMichael F Sharpnack, Ju Hwan Cho, Travis S Johnson, et al.
International Journal of Cancer|July 24, 2009
Elevated lung cancer risk is associated with deficiencies in cell cycle checkpoints: genotype and phenotype analyses from a case-control studyYun-Ling Zheng, Ourania Kosti, Christopher A Loffredo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 5, 2009
Methods used in internal industry clinical trials to assess tobacco risk reductionVaughan W Rees, Jennifer M Kreslake, Richard J O'Connor, et al.
Journal of the National Cancer Institute|September 13, 2007
Lung cancer survival and functional polymorphisms in MBL2, an innate-immunity geneSharon R Pine, Leah E Mechanic, Stefan Ambs, et al.
Addiction (Abingdon, England)|September 11, 2016
Reduced nicotine content cigarettes and use of alternative nicotine products: exploratory trialDorothy K Hatsukami, Xianghua Luo, Laura Dick, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 5, 2009
Assessing consumer responses to potential reduced-exposure tobacco products: a review of tobacco industry and independent research methodsVaughan W Rees, Jennifer M Kreslake, K Michael Cummings, et al.
Pharmacogenetics and Genomics|May 19, 2005
Association of catechol-O-methyltransferase with smoking cessation in two independent studies of womenSusan Colilla, Caryn Lerman, Peter G Shields, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 15, 2014
Genetic variation in adipokine genes and associations with adiponectin and leptin concentrations in plasma and breast tissueAdana A M Llanos, Theodore M Brasky, Jeena Mathew, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
TP53 mutation spectrum in lung cancer is not different in women and menAizen J Marrogi, Leah E Mechanic, Judith A Welsh, et al.
Pageof 22